Brief: Shenzhen Hepalink Pharmaceutical Says Proposed Distribution Of Final Cash Dividend Of RMB0.35/Ten Shares For Year
11/04/2022 14:02
April 11 (Reuters) - Shenzhen Hepalink Pharmaceutical Group
Co Ltd 002399.SZ :
* PROPOSED DISTRIBUTION OF FINAL CASH DIVIDEND OF RMB0.35
PER TEN
ORDINARY SHARES FOR YEAR 2021
* FY SALES INCREASED BY 19.6% TO RMB6,359.8 MILLION
* FY GROSS PROFIT RMB1,993.6 MILLION VERSUS RMB2,016.8
MILLION
Further company coverage: 002399.SZ
Recent news on Shenzhen Hepalink Pharmaceutical Co
See all newsBrief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina
Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA